Copyright Reports & Markets. All rights reserved.

Global Chronic Hepatitis B Virus Testing Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Chronic Hepatitis B Virus Testing Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Enzyme Immunoassay Kits
    • 1.3.3 Hepatitis B Surface Antigen Test
    • 1.3.4 Anti-Hepatitis B Surface Antibody Test
    • 1.3.5 Anti-Hepatitis B Core Antibody Test
    • 1.3.6 Point-of-Care Testing Kits
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Chronic Hepatitis B Virus Testing Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospitals
    • 1.4.3 Clinics
    • 1.4.4 Diagnostic Centers
    • 1.4.5 Home
  • 1.5 Global Chronic Hepatitis B Virus Testing Market Size & Forecast
    • 1.5.1 Global Chronic Hepatitis B Virus Testing Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Chronic Hepatitis B Virus Testing Sales Quantity (2021-2032)
    • 1.5.3 Global Chronic Hepatitis B Virus Testing Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Gilead Sciences
    • 2.1.1 Gilead Sciences Details
    • 2.1.2 Gilead Sciences Major Business
    • 2.1.3 Gilead Sciences Chronic Hepatitis B Virus Testing Product and Services
    • 2.1.4 Gilead Sciences Chronic Hepatitis B Virus Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Gilead Sciences Recent Developments/Updates
  • 2.2 GlaxoSmithKline
    • 2.2.1 GlaxoSmithKline Details
    • 2.2.2 GlaxoSmithKline Major Business
    • 2.2.3 GlaxoSmithKline Chronic Hepatitis B Virus Testing Product and Services
    • 2.2.4 GlaxoSmithKline Chronic Hepatitis B Virus Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 GlaxoSmithKline Recent Developments/Updates
  • 2.3 Ionis Pharma
    • 2.3.1 Ionis Pharma Details
    • 2.3.2 Ionis Pharma Major Business
    • 2.3.3 Ionis Pharma Chronic Hepatitis B Virus Testing Product and Services
    • 2.3.4 Ionis Pharma Chronic Hepatitis B Virus Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Ionis Pharma Recent Developments/Updates
  • 2.4 Janssen Sciences Ireland
    • 2.4.1 Janssen Sciences Ireland Details
    • 2.4.2 Janssen Sciences Ireland Major Business
    • 2.4.3 Janssen Sciences Ireland Chronic Hepatitis B Virus Testing Product and Services
    • 2.4.4 Janssen Sciences Ireland Chronic Hepatitis B Virus Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Janssen Sciences Ireland Recent Developments/Updates
  • 2.5 Assembly Biosciences
    • 2.5.1 Assembly Biosciences Details
    • 2.5.2 Assembly Biosciences Major Business
    • 2.5.3 Assembly Biosciences Chronic Hepatitis B Virus Testing Product and Services
    • 2.5.4 Assembly Biosciences Chronic Hepatitis B Virus Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Assembly Biosciences Recent Developments/Updates
  • 2.6 Janssen and Arrowhead Pharmaceuticals
    • 2.6.1 Janssen and Arrowhead Pharmaceuticals Details
    • 2.6.2 Janssen and Arrowhead Pharmaceuticals Major Business
    • 2.6.3 Janssen and Arrowhead Pharmaceuticals Chronic Hepatitis B Virus Testing Product and Services
    • 2.6.4 Janssen and Arrowhead Pharmaceuticals Chronic Hepatitis B Virus Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Janssen and Arrowhead Pharmaceuticals Recent Developments/Updates
  • 2.7 Roche
    • 2.7.1 Roche Details
    • 2.7.2 Roche Major Business
    • 2.7.3 Roche Chronic Hepatitis B Virus Testing Product and Services
    • 2.7.4 Roche Chronic Hepatitis B Virus Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Roche Recent Developments/Updates
  • 2.8 Vir Biotechnology
    • 2.8.1 Vir Biotechnology Details
    • 2.8.2 Vir Biotechnology Major Business
    • 2.8.3 Vir Biotechnology Chronic Hepatitis B Virus Testing Product and Services
    • 2.8.4 Vir Biotechnology Chronic Hepatitis B Virus Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Vir Biotechnology Recent Developments/Updates
  • 2.9 Bio-Rad Laboratories, Inc.
    • 2.9.1 Bio-Rad Laboratories, Inc. Details
    • 2.9.2 Bio-Rad Laboratories, Inc. Major Business
    • 2.9.3 Bio-Rad Laboratories, Inc. Chronic Hepatitis B Virus Testing Product and Services
    • 2.9.4 Bio-Rad Laboratories, Inc. Chronic Hepatitis B Virus Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Bio-Rad Laboratories, Inc. Recent Developments/Updates
  • 2.10 DiaSorin S.p.A.
    • 2.10.1 DiaSorin S.p.A. Details
    • 2.10.2 DiaSorin S.p.A. Major Business
    • 2.10.3 DiaSorin S.p.A. Chronic Hepatitis B Virus Testing Product and Services
    • 2.10.4 DiaSorin S.p.A. Chronic Hepatitis B Virus Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 DiaSorin S.p.A. Recent Developments/Updates
  • 2.11 Abbott Laboratories
    • 2.11.1 Abbott Laboratories Details
    • 2.11.2 Abbott Laboratories Major Business
    • 2.11.3 Abbott Laboratories Chronic Hepatitis B Virus Testing Product and Services
    • 2.11.4 Abbott Laboratories Chronic Hepatitis B Virus Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Abbott Laboratories Recent Developments/Updates
  • 2.12 Meridian Bioscience
    • 2.12.1 Meridian Bioscience Details
    • 2.12.2 Meridian Bioscience Major Business
    • 2.12.3 Meridian Bioscience Chronic Hepatitis B Virus Testing Product and Services
    • 2.12.4 Meridian Bioscience Chronic Hepatitis B Virus Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Meridian Bioscience Recent Developments/Updates

3 Competitive Environment: Chronic Hepatitis B Virus Testing by Manufacturer

  • 3.1 Global Chronic Hepatitis B Virus Testing Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Chronic Hepatitis B Virus Testing Revenue by Manufacturer (2021-2026)
  • 3.3 Global Chronic Hepatitis B Virus Testing Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Chronic Hepatitis B Virus Testing by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Chronic Hepatitis B Virus Testing Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Chronic Hepatitis B Virus Testing Manufacturer Market Share in 2025
  • 3.5 Chronic Hepatitis B Virus Testing Market: Overall Company Footprint Analysis
    • 3.5.1 Chronic Hepatitis B Virus Testing Market: Region Footprint
    • 3.5.2 Chronic Hepatitis B Virus Testing Market: Company Product Type Footprint
    • 3.5.3 Chronic Hepatitis B Virus Testing Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Chronic Hepatitis B Virus Testing Market Size by Region
    • 4.1.1 Global Chronic Hepatitis B Virus Testing Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Chronic Hepatitis B Virus Testing Consumption Value by Region (2021-2032)
    • 4.1.3 Global Chronic Hepatitis B Virus Testing Average Price by Region (2021-2032)
  • 4.2 North America Chronic Hepatitis B Virus Testing Consumption Value (2021-2032)
  • 4.3 Europe Chronic Hepatitis B Virus Testing Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Chronic Hepatitis B Virus Testing Consumption Value (2021-2032)
  • 4.5 South America Chronic Hepatitis B Virus Testing Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Chronic Hepatitis B Virus Testing Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Chronic Hepatitis B Virus Testing Sales Quantity by Type (2021-2032)
  • 5.2 Global Chronic Hepatitis B Virus Testing Consumption Value by Type (2021-2032)
  • 5.3 Global Chronic Hepatitis B Virus Testing Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Chronic Hepatitis B Virus Testing Sales Quantity by Application (2021-2032)
  • 6.2 Global Chronic Hepatitis B Virus Testing Consumption Value by Application (2021-2032)
  • 6.3 Global Chronic Hepatitis B Virus Testing Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Chronic Hepatitis B Virus Testing Sales Quantity by Type (2021-2032)
  • 7.2 North America Chronic Hepatitis B Virus Testing Sales Quantity by Application (2021-2032)
  • 7.3 North America Chronic Hepatitis B Virus Testing Market Size by Country
    • 7.3.1 North America Chronic Hepatitis B Virus Testing Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Chronic Hepatitis B Virus Testing Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Chronic Hepatitis B Virus Testing Sales Quantity by Type (2021-2032)
  • 8.2 Europe Chronic Hepatitis B Virus Testing Sales Quantity by Application (2021-2032)
  • 8.3 Europe Chronic Hepatitis B Virus Testing Market Size by Country
    • 8.3.1 Europe Chronic Hepatitis B Virus Testing Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Chronic Hepatitis B Virus Testing Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Chronic Hepatitis B Virus Testing Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Chronic Hepatitis B Virus Testing Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Chronic Hepatitis B Virus Testing Market Size by Region
    • 9.3.1 Asia-Pacific Chronic Hepatitis B Virus Testing Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Chronic Hepatitis B Virus Testing Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Chronic Hepatitis B Virus Testing Sales Quantity by Type (2021-2032)
  • 10.2 South America Chronic Hepatitis B Virus Testing Sales Quantity by Application (2021-2032)
  • 10.3 South America Chronic Hepatitis B Virus Testing Market Size by Country
    • 10.3.1 South America Chronic Hepatitis B Virus Testing Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Chronic Hepatitis B Virus Testing Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Chronic Hepatitis B Virus Testing Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Chronic Hepatitis B Virus Testing Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Chronic Hepatitis B Virus Testing Market Size by Country
    • 11.3.1 Middle East & Africa Chronic Hepatitis B Virus Testing Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Chronic Hepatitis B Virus Testing Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Chronic Hepatitis B Virus Testing Market Drivers
  • 12.2 Chronic Hepatitis B Virus Testing Market Restraints
  • 12.3 Chronic Hepatitis B Virus Testing Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Chronic Hepatitis B Virus Testing and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Chronic Hepatitis B Virus Testing
  • 13.3 Chronic Hepatitis B Virus Testing Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Chronic Hepatitis B Virus Testing Typical Distributors
  • 14.3 Chronic Hepatitis B Virus Testing Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Chronic Hepatitis B Virus Testing market size was valued at US$ 1067 million in 2025 and is forecast to a readjusted size of US$ 1675 million by 2032 with a CAGR of 6.7% during review period.
    Chronic Hepatitis B Virus (HBV) testing refers to a series of laboratory tests that detect the presence of the virus in the blood over an extended period. Chronic hepatitis B is a condition in which the HBV infection lasts for more than six months.
    This report is a detailed and comprehensive analysis for global Chronic Hepatitis B Virus Testing market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Chronic Hepatitis B Virus Testing market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Chronic Hepatitis B Virus Testing market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Chronic Hepatitis B Virus Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Chronic Hepatitis B Virus Testing market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Chronic Hepatitis B Virus Testing
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Chronic Hepatitis B Virus Testing market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gilead Sciences, GlaxoSmithKline, Ionis Pharma, Janssen Sciences Ireland, Assembly Biosciences, Janssen and Arrowhead Pharmaceuticals, Roche, Vir Biotechnology, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Chronic Hepatitis B Virus Testing market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Enzyme Immunoassay Kits
    Hepatitis B Surface Antigen Test
    Anti-Hepatitis B Surface Antibody Test
    Anti-Hepatitis B Core Antibody Test
    Point-of-Care Testing Kits
    Market segment by Application
    Hospitals
    Clinics
    Diagnostic Centers
    Home
    Major players covered
    Gilead Sciences
    GlaxoSmithKline
    Ionis Pharma
    Janssen Sciences Ireland
    Assembly Biosciences
    Janssen and Arrowhead Pharmaceuticals
    Roche
    Vir Biotechnology
    Bio-Rad Laboratories, Inc.
    DiaSorin S.p.A.
    Abbott Laboratories
    Meridian Bioscience
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Chronic Hepatitis B Virus Testing product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Chronic Hepatitis B Virus Testing, with price, sales quantity, revenue, and global market share of Chronic Hepatitis B Virus Testing from 2021 to 2026.
    Chapter 3, the Chronic Hepatitis B Virus Testing competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Chronic Hepatitis B Virus Testing breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Chronic Hepatitis B Virus Testing market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Chronic Hepatitis B Virus Testing.
    Chapter 14 and 15, to describe Chronic Hepatitis B Virus Testing sales channel, distributors, customers, research findings and conclusion.

    Buy now